CYH 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

03
가격 $2.72
시가총액 (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
매출 (TTM) $11.98B
ROE (TTM) -16.7%
부채/자본 (MRQ) -6.9
52주 범위 $2–$4

CYH 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

04
범위
막대

막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.

주식 분할 1
배당락일 분할 유형
2016년 4월 22일 121-for-100 정방향

Community Health Systems, Inc. Common Stock 정보 위키백과 회사 개요

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

섹터Health Care 산업Health Care 직원44,000 국가US

10년 성과 매출, 순이익, 마진 및 EPS 추세

06
매출$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
잉여현금흐름$208M
2016-12-31 → 2025-12-31
순이익률2.1%
2018-12-31 → 2025-12-31
가치 평가 및 비율 07–12

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표 5년 추세 CYH 5년 평균 동종업계 중앙값 결론
P/E (TTM) 1.55년 평균 ≈3.4 ≈3.4 15.5 저평가
P/S (TTM) 0.05년 평균 ≈0.1 ≈0.1 1.2 저평가
P/B (MRQ) -0.35년 평균 ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.15년 평균 ≈13.1 ≈13.1 10.6 저평가
주가 / FCF (TTM) -2.15년 평균 ≈-0.8 ≈-0.8 · ·
주가 / 현금 흐름 (TTM) 3.05년 평균 ≈-1.6 ≈-1.6 6.5 저평가
EV / Revenue (EV / 매출) 0.85년 평균 ≈1.0 ≈1.0 · ·
EV / FCF 50.55년 평균 ≈-4.9 ≈-4.9 · ·

동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.

가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가

배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR

13
배당락일금액통화수익률
12월 13, 2012$0.21USD≈0.84%

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

14
평균 서프라이즈 37.9%
다음 실적 10월 21, 2026
기간보고서EPS ActualEPS 예상서프라이즈
2026년 6월 30일 7월 21, 2026 $-0.19 $-0.06 -201.1%
2026년 3월 31일 $-0.48 $-0.10 -387.3%
2025년 12월 31일 $-0.01 $-0.10 90.5%
2025년 9월 30일 $1.27 $-0.25 610.5%
2025년 6월 30일 $-0.05 $-0.11 52.6%
2025년 3월 31일 $-0.03 $-0.08 62.6%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

15
손익계산서 13
지표 추세 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
대차대조표 26
지표 추세 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
현금 흐름 13
지표 추세 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
수익성 7
지표 추세 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
유동성 및 지급능력 4
지표 추세 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
효율성 2
지표 추세 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
주당 5
지표 추세 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
성장률 9
지표 추세 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
가치 평가 (TTM) 13
지표 추세 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

최신 기간은 왼쪽에 · null 값은 ·로 표시

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

16
지표 2025-12-312024-12-312023-12-312022-12-312021-12-31
매출 $12.48B $12.63B $12.49B $12.21B $12.37B
영업이익률 % 11.9% 4.3% 7.7% 6.7% 11.3%
순이익 $509M $-516M $-133M $46M $230M
희석 EPS $3.77 $-3.90 $-1.02 $0.35 $1.76

기관 투자자 (13F) 196개의 제출자 · $415.1M 전체 · 기준일 2026년 9월 30일

17

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

보유자 196
보유 가치 $415.1M
신규 포지션 31
청산 포지션 24
기관 활동 — Q2 2026 대 이전 분기
신규 포지션 청산 포지션 증가함 감소 순주식 변동
31 (+9 이전 분기 대비) 24 (+4 이전 분기 대비) 69 (+6 이전 분기 대비) 54 (-9 이전 분기 대비) +7.0M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관 가치 주식 % 추적된 13F 중 유형
CastleKnight Management LP $44,704,517 13,384,586 10.77% 주식
Apollo Management Holdings, L.P. $39,610,817 11,859,526 9.54% 주식
BlackRock, Inc. $36,507,995 10,930,538 8.79% 주식
VANGUARD GROUP INC $28,605,579 9,168,455 6.89% 주식
Eversept Partners, LP $26,267,680 7,864,575 6.33% 주식
NOMURA HOLDINGS INC $22,388,384 6,703,109 5.39% 주식
VANGUARD CAPITAL MANAGEMENT LLC $17,668,370 5,289,931 4.26% 주식
WHITEBOX ADVISORS LLC $12,467,362 3,732,743 3.00% 주식
GEODE CAPITAL MANAGEMENT, LLC $10,582,352 3,167,702 2.55% 주식
STATE STREET CORP $10,226,622 3,061,863 2.46% 주식
VANGUARD PORTFOLIO MANAGEMENT LLC $10,082,117 3,018,598 2.43% 주식
Saba Capital Management, L.P. $9,626,444 2,882,169 2.32% 주식
Owl Creek Asset Management, L.P. $8,452,277 2,530,622 2.04% 주식
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8,176,380 2,448,018 1.97% 주식
DIMENSIONAL FUND ADVISORS LP $7,854,253 2,351,460 1.89% 주식
D. E. Shaw & Co., Inc. $7,829,388 2,344,128 1.89% 주식
AQR CAPITAL MANAGEMENT LLC $7,651,362 2,290,827 1.84% 주식
TWO SIGMA INVESTMENTS, LP $7,365,822 2,205,336 1.77% 주식
Diameter Capital Partners LP $6,138,793 1,837,962 1.48% 주식
BANK OF AMERICA CORP /DE/ $5,903,847 1,767,619 1.42% 주식
GOLDMAN SACHS GROUP INC $5,868,073 1,756,908 1.41% 주식
TWO SIGMA ADVISERS, LP $5,816,476 1,864,255 1.40% 주식
CARRONADE CAPITAL MANAGEMENT, LP $5,230,000 1,565,847 1.26% 주식
Allianz Asset Management GmbH $5,167,919 1,547,281 1.24% 주식
MORGAN STANLEY $4,800,489 1,437,272 1.16% 주식
NORTHERN TRUST CORP $4,681,414 1,401,621 1.13% 주식
Silver Rock Financial LP $3,674,000 1,100,000 0.89% 주식
CITADEL ADVISORS LLC $3,475,360 1,040,527 0.84% 주식
Assenagon Asset Management S.A. $2,788,275 834,813 0.67% 주식
VANGUARD FIDUCIARY TRUST CO $2,642,231 791,087 0.64% 주식
Jefferies Financial Group Inc. $2,481,286 742,900 0.60% 주식
Alta Fundamental Advisers LLC $2,161,411 647,129 0.52% 주식
Bank of New York Mellon Corp $2,122,084 635,354 0.51% 주식
MARSHALL WACE, LLP $1,906,575 570,831 0.46% 주식
MILLENNIUM MANAGEMENT LLC $1,701,580 509,455 0.41% 주식
ExodusPoint Capital Management, LP $1,664,603 498,384 0.40% 주식
READYSTATE ASSET MANAGEMENT LP $1,657,729 496,326 0.40% 주식
WOLVERINE ASSET MANAGEMENT LLC $1,339,674 401,100 0.32% 콜 옵션
Helix Partners Management LP $1,336,000 400,000 0.32% 주식
Susquehanna Portfolio Strategies, LLC $1,280,940 383,515 0.31% 주식
Voleon Capital Management LP $1,247,032 373,363 0.30% 주식
Invesco Ltd. $1,076,599 322,335 0.26% 주식
TUDOR INVESTMENT CORP ET AL $999,388 299,218 0.24% 주식
Pathstone Holdings, LLC $895,621 268,150 0.22% 주식
Prescott Group Capital Management, L.L.C. $863,076 258,406 0.21% 주식
UBS Group AG $851,089 254,817 0.21% 주식
MILLENNIUM MANAGEMENT LLC $835,000 250,000 0.20% 풋 옵션
FEDERATED HERMES, INC. $812,599 243,293 0.20% 주식
LPL Financial LLC $737,239 220,730 0.18% 주식
IEQ CAPITAL, LLC $657,963 196,995 0.16% 주식

전체 196 기관 투자자 보기 →

행동주의자 및 5% 이상 소유자 1 보유

18

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자 제출됨 지분 상태 목적 제출
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 제출 서류 2021년 3월 11일 · 최초 제출 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

회사 내부자 56 명의 내부자 · 29 임원 · 23 이사

19
내부자 역할 마지막 활동 보유 주식 수 매수 12개월 매도 12개월 순매수/매도 12개월
Kevin J Hammons CEO 2026년 3월 1일 A 895,545 0 0 $0
Tim Hingtgen CEO 2025년 3월 1일 A 1,388,781 0 0 $0
Jason K Johnson EVP & CFO 2026년 3월 1일 A 268,439 0 0 $0
Thomas J Aaron EVP and CFO 2019년 12월 7일 F 241,515 0 0 $0
Larry W Cash President and CFO 2017년 3월 1일 A 568,152 0 0 $0
Miguel S Benet President and CMO 2025년 3월 1일 D 47,635 0 0 $0
Austen D Mason Regional President 2025년 3월 1일 A 142,500 0 0 $0
Mark B Medley Regional President 2025년 3월 1일 A 128,637 0 0 $0
Chad A Campbell Regional President 2025년 3월 1일 A 136,815 0 0 $0
Charles J Cova Regional President 2024년 3월 1일 A 58,701 0 0 $0
Lynn T Simon President and CMO 2024년 3월 1일 A 482,657 0 0 $0
Beryl Ramsey Division President 2019년 3월 1일 A 62,969 0 0 $0
Patton Paul Smith Division President 2019년 3월 1일 F 119,017 0 0 $0
Iii John W Mcclellan Division President 2017년 3월 1일 A 41,242 0 0 $0
Robert O Horrar Division President 2017년 3월 1일 A 68,649 0 0 $0
Martin Bonick Division President 2017년 3월 1일 A 100,458 0 0 $0
Michael T Portacci Division President 2017년 3월 1일 A 110,156 0 0 $0
Thomas Daniel Miller Division President 2016년 3월 1일 A 112,107 0 0 $0
David Lewis Miller President and COO 2016년 3월 1일 A 440,840 0 0 $0
William S Hussey Division President 2015년 10월 28일 M 121,568 0 0 $0
Martin Dewayne Smith Division President 2015년 6월 3일 M 94,111 0 0 $0
Gary D Newsome Division President - Group Ops 2008년 8월 25일 M 118,286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 2026년 6월 1일 A 30,000 0 0 $0
Phillip A. Posey SVP & CAO 2026년 3월 1일 A 51,736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 2026년 3월 1일 A 287,750 0 0 $0
Kevin A Stockton EVP, Operations & Development 2026년 3월 1일 A 208,290 0 0 $0
Rachel A Seifert Executive VP and Secretary 2017년 3월 1일 F 243,065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 2012년 2월 25일 F 78,379 0 0 $0
Martin G Schweinhart Senior Vice President 2006년 3월 1일 A 40,354 0 0 $0
William Norris Jennings 이사 2026년 8월 25일 S 38,468 0 1 $-118,400
Ranga K Krishnan 이사 2026년 6월 30일 M 170,023 0 0 $0
Fawn D Lopez 이사 2026년 3월 1일 A · 0 0 $0
Ronald L Burgess JR 이사 2026년 3월 1일 A · 0 0 $0
Susan W Brooks 이사 2026년 3월 1일 A 108,695 0 0 $0
Hubert James Williams 이사 2026년 3월 1일 A 211,863 0 0 $0
Joseph Arthur Hastings 이사 2026년 3월 1일 A 0 0 0 $0
Elizabeth T Hirsch 이사 2026년 3월 1일 A 162,059 0 0 $0
James S. Ely III 이사 2026년 3월 1일 A 412,876 0 0 $0
John A Fry 이사 2026년 3월 1일 A 268,966 0 0 $0
John A Clerico 이사 2026년 3월 1일 A 368,763 0 0 $0
Michael Dinkins 이사 2026년 3월 1일 A 225,882 0 0 $0
Wayne T Smith 이사 2026년 3월 1일 A 5,217,579 0 0 $0
Julia B North 이사 2021년 3월 1일 A 162,056 0 0 $0
Mitchell H Watson JR 이사 2017년 5월 16일 M 22,594 0 0 $0
Harvey Klein MD 이사 2010년 3월 15일 M 10,383 0 0 $0
Dale F Frey 이사 2008년 3월 31일 A 20,000 0 0 $0
Thomas H Lister 이사 2004년 9월 21일 S 0 0 0 $0
Thodore Forstmann 이사 2004년 9월 21일 S 0 0 0 $0
Sandra Horbach 이사 2004년 9월 21일 S 0 0 0 $0
Robert J Dole 이사 2004년 5월 6일 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10% 소유주 2004년 9월 21일 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10% 소유주 2004년 9월 21일 S 0 0 0 $0
Winston Hutchins 10% 소유주 2004년 9월 21일 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10% 소유주 2004년 9월 21일 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10% 소유주 2004년 9월 21일 S 0 0 0 $0
Benjamin C Fordham · 2021년 3월 1일 A 254,608 0 0 $0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

ETF 보유 현황 25 ETF 보유

20

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드 비중 단위 기준일 출처
BSJR · Invesco Exchange-Traded Self-Indexe… 2.85% 24,817,000 2026년 10월 2일 일간
EBIT · Harbor ETF Trust 0.45% 19,210 NS 2026년 7월 31일 N-PORT
IWC · iShares Trust 0.09% 443,690 SH 2026년 9월 11일 일간
IHF · iShares Trust 0.05% 223,947 SH 2026년 9월 11일 일간
VTWV · VANGUARD SCOTTSDALE FUNDS 0.03% 113,109 SH 2026년 8월 19일 일간
NEAR · iShares U.S. ETF Trust 0.03% 1,340,000 SH 2026년 9월 11일 일간
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 221,871 SH 2026년 10월 2일 일간
IWM · iShares Trust 0.01% 3,425,206 SH 2026년 9월 11일 일간
RSSL · Global X Funds 0.01% 62,038 NS 2026년 7월 31일 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 746,733 SH 2026년 8월 19일 일간
VHT · VANGUARD WORLD FUND 0.01% 349,881 SH 2026년 8월 19일 일간
DFAS · Dimensional ETF Trust 0.01% 289,348 NS 2026년 7월 31일 N-PORT
DFAC · Dimensional ETF Trust 0.00% 202,789 NS 2026년 7월 31일 N-PORT
DFAU · Dimensional ETF Trust 0.00% 33,838 NS 2026년 7월 31일 N-PORT
ITOT · iShares Trust 0.00% 203,848 SH 2026년 9월 11일 일간
IWV · iShares Trust 0.00% 42,177 SH 2026년 9월 3일 일간
DCOR · Dimensional ETF Trust 0.00% 6,184 NS 2026년 7월 31일 N-PORT
DFUS · Dimensional ETF Trust 0.00% 31,135 NS 2026년 7월 31일 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 1,347,195 SH 2026년 8월 19일 일간
VTI · VANGUARD INDEX FUNDS 0.00% 3,813,888 SH 2026년 8월 19일 일간
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 9,817 SH 2026년 8월 19일 일간
DFSU · Dimensional ETF Trust 0.00% 24 NS 2026년 7월 31일 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 2026년 7월 15일 일간
VPLS · VANGUARD MALVERN FUNDS · · 2026년 7월 15일 일간
IWN · iShares Trust · 1,223,127 SH 2026년 9월 11일 일간

CYH 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

21
평점 · 16 명의 애널리스트 보유
중앙값 목표 $3.12 +14.9%
1 6.2% 적극 매수
1 6.2% 매수
6 37.5% 보유
7 43.8% 매도
1 6.2% 적극 매도

12개월 목표 주가

8 명의 애널리스트 · 2026-10-01

평균 목표 $3.16 +16.0%

지금 현재가 $2.72
저가$2.00 평균$3.16 고가$4.00

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

22

회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

최신 뉴스 이 회사 관련 최근 헤드라인

23

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

26

중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

출처: SEC 10-Q 제출 7월 23, 2026